Dave C. Iannetta , MBA
David Iannetta, MBA, serves as the Consulting Chief Business Officer for OTI, bringing over 20 years of leadership in biotechnology commercialization, regulatory strategy, and corporate growth. He is widely recognized for his success at Avedro, Inc., where he served as VP of Marketing and was an integral part of the executive team that navigated the company from initial product development through its IPO and subsequent $500M acquisition by Glaukos. David’s extensive ophthalmic expertise is highlighted by his leadership in launching first-in-class treatments for keratoconus and dry eye disease, for which he earned several prestigious industry honors, including an MM&M Gold Award.
In addition to his commercial prowess, David is a co-inventor of several US patents, including innovations in corneal cross-linking distribution. He earned his MBA from the MIT Sloan School of Management and a BS in Chemical Engineering from Lehigh University. As a dedicated mentor and thought leader in the life sciences industry, David also co-hosts the "LifeSci Continuum" podcast, where he shares strategic insights on pharmaceutical launches and investor relations to help founders and executives position their innovations for long-term success.
